The global tissue plasminogen activator market is estimated to be valued at US$ 614.9 Mn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period of 2024 to 2030.
Tissue plasminogen activator (tPA) is a protein involved in the breakdown of blood clots. It helps restore blood flow by dissolving clots and is primarily used for the treatment of ischemic stroke and myocardial...
0 Commentarios
0 Acciones
426 Views
0 Vista previa